OGSG2101:Efficacy and Safety of BEACON triplet regimen for early relapse BRAF-mutated colorectal cancer
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Interventions: Encorafenib,binimetinib,cetuximab Primary outcome(s): Objective response rate Study Design: single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose
创建时间：
2022-01-15
